entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
100506473,C2orf49-DT,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,179.742856791467,-0.397674763793894,0.161789949087543,-2.4579695218194,0.0139725031604724,0.0985534847328832,NA
100506473,C2orf49-DT,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,155.431567349004,-0.02344486688679,0.154958603545129,-0.15129761336525,0.87974095186978,0.984623569400534,patient-derived GBM cell lines (PDGCLs)
100506473,C2orf49-DT,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,48.3413680510774,0.147732873810264,0.300265973568112,0.492006710100144,0.622714599976793,0.933906632050025,A549
100506473,C2orf49-DT,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,88.4971510667091,0.191284381788053,0.226615969711159,0.844090476200159,0.398618849216574,0.986418245486816,A549
100506473,C2orf49-DT,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,38.2369165143501,-0.906870118089101,0.498948492167121,-1.81756259879697,0.0691310124534386,0.180800802534924,A549
100506473,C2orf49-DT,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,55.3638386265956,0.00393825072633676,0.31401273323624,0.0125416911784081,0.989993440571734,1,sigmoid colon organoid
100506473,C2orf49-DT,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,55.3638386265956,0.0391368117833731,0.312894953801923,0.125079715437496,0.900460441905477,1,sigmoid colon organoid
